OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis
Kevin T. Nead, Sumi Sinha, Paul L. Nguyen
Prostate Cancer and Prostatic Diseases (2017) Vol. 20, Iss. 3, pp. 259-264
Closed Access | Times Cited: 66
Kevin T. Nead, Sumi Sinha, Paul L. Nguyen
Prostate Cancer and Prostatic Diseases (2017) Vol. 20, Iss. 3, pp. 259-264
Closed Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation
Lei Yang, Renyuan Zhou, Tong Yu, et al.
Neurobiology of Disease (2020) Vol. 140, pp. 104814-104814
Open Access | Times Cited: 173
Lei Yang, Renyuan Zhou, Tong Yu, et al.
Neurobiology of Disease (2020) Vol. 140, pp. 104814-104814
Open Access | Times Cited: 173
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
Katherine S. Virgo, R. Bryan Rumble, Ronald de Wit, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 11, pp. 1274-1305
Open Access | Times Cited: 90
Katherine S. Virgo, R. Bryan Rumble, Ronald de Wit, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 11, pp. 1274-1305
Open Access | Times Cited: 90
Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease
Zhangsen Huang, Lik‐Wei Wong, Yixun Su, et al.
Frontiers in Neuroendocrinology (2020) Vol. 59, pp. 100857-100857
Open Access | Times Cited: 87
Zhangsen Huang, Lik‐Wei Wong, Yixun Su, et al.
Frontiers in Neuroendocrinology (2020) Vol. 59, pp. 100857-100857
Open Access | Times Cited: 87
Impact of Testosterone on Alzheimer’s Disease
Vittorio Emanuele Bianchi
The World Journal of Men s Health (2022) Vol. 40, Iss. 2, pp. 243-243
Open Access | Times Cited: 44
Vittorio Emanuele Bianchi
The World Journal of Men s Health (2022) Vol. 40, Iss. 2, pp. 243-243
Open Access | Times Cited: 44
Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study
Ross J. Marriott, Kevin Murray, Leon Flicker, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 10, pp. 1907-1918
Closed Access | Times Cited: 39
Ross J. Marriott, Kevin Murray, Leon Flicker, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 10, pp. 1907-1918
Closed Access | Times Cited: 39
Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study
Huah Shin Ng, Bogda Koczwara, David Roder, et al.
Prostate Cancer and Prostatic Diseases (2018) Vol. 21, Iss. 3, pp. 403-410
Closed Access | Times Cited: 49
Huah Shin Ng, Bogda Koczwara, David Roder, et al.
Prostate Cancer and Prostatic Diseases (2018) Vol. 21, Iss. 3, pp. 403-410
Closed Access | Times Cited: 49
Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
Marlon Perera, Matthew J. Roberts, Laurence Klotz, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 8, pp. 469-481
Closed Access | Times Cited: 47
Marlon Perera, Matthew J. Roberts, Laurence Klotz, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 8, pp. 469-481
Closed Access | Times Cited: 47
An Updated Review: Androgens and Cognitive Impairment in Older Men
Zhonglin Cai, Hongjun Li
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 47
Zhonglin Cai, Hongjun Li
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 47
Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review
Kim Edmunds, Haitham Tuffaha, Daniel A. Galvão, et al.
Supportive Care in Cancer (2020) Vol. 28, Iss. 5, pp. 2079-2093
Closed Access | Times Cited: 45
Kim Edmunds, Haitham Tuffaha, Daniel A. Galvão, et al.
Supportive Care in Cancer (2020) Vol. 28, Iss. 5, pp. 2079-2093
Closed Access | Times Cited: 45
Testosterone, cognitive decline and dementia in ageing men
Bu B. Yeap, Leon Flicker
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 6, pp. 1243-1257
Open Access | Times Cited: 24
Bu B. Yeap, Leon Flicker
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 6, pp. 1243-1257
Open Access | Times Cited: 24
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
Androgen deprivation therapy and dementia risk: An updated and dose-response meta-analysis
Shun Zhu, Jingnian Ni, Siwei Long, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Shun Zhu, Jingnian Ni, Siwei Long, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Thyroid Disorders and Dementia Risk
Daniel R. Wieland, Julia R. Wieland, Han Wang, et al.
Neurology (2022) Vol. 99, Iss. 7
Closed Access | Times Cited: 20
Daniel R. Wieland, Julia R. Wieland, Han Wang, et al.
Neurology (2022) Vol. 99, Iss. 7
Closed Access | Times Cited: 20
Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
Miguel Garcia‐Argibay, Ayako Hiyoshi, Katja Fall, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2248135-e2248135
Open Access | Times Cited: 19
Miguel Garcia‐Argibay, Ayako Hiyoshi, Katja Fall, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2248135-e2248135
Open Access | Times Cited: 19
Impact of androgen deprivation therapy on mood, cognition, and risk for AD
Monique M. Cherrier, Celestia S. Higano
Urologic Oncology Seminars and Original Investigations (2019) Vol. 38, Iss. 2, pp. 53-61
Open Access | Times Cited: 32
Monique M. Cherrier, Celestia S. Higano
Urologic Oncology Seminars and Original Investigations (2019) Vol. 38, Iss. 2, pp. 53-61
Open Access | Times Cited: 32
Androgen deprivation therapy and side effects
Stephen J. Freedland, Per‐Anders Abrahamsson
Asian Journal of Andrology (2020) Vol. 23, Iss. 1, pp. 3-10
Open Access | Times Cited: 30
Stephen J. Freedland, Per‐Anders Abrahamsson
Asian Journal of Andrology (2020) Vol. 23, Iss. 1, pp. 3-10
Open Access | Times Cited: 30
Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation
Jennifer Beebe‐Dimmer, Julie J. Ruterbusch, Kathleen A. Cooney, et al.
Cancer Medicine (2019) Vol. 8, Iss. 6, pp. 3325-3335
Open Access | Times Cited: 28
Jennifer Beebe‐Dimmer, Julie J. Ruterbusch, Kathleen A. Cooney, et al.
Cancer Medicine (2019) Vol. 8, Iss. 6, pp. 3325-3335
Open Access | Times Cited: 28
Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease
Lei Yang, Renyuan Zhou
Endocrinology (2018) Vol. 159, Iss. 12, pp. 3885-3894
Open Access | Times Cited: 27
Lei Yang, Renyuan Zhou
Endocrinology (2018) Vol. 159, Iss. 12, pp. 3885-3894
Open Access | Times Cited: 27
Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition
Jason Izard, D. Robert Siemens
European Urology Focus (2020) Vol. 6, Iss. 6, pp. 1162-1164
Closed Access | Times Cited: 23
Jason Izard, D. Robert Siemens
European Urology Focus (2020) Vol. 6, Iss. 6, pp. 1162-1164
Closed Access | Times Cited: 23
Risk of Alzheimer’s Disease in Cancer Patients: Analysis of Mortality Data from the US SEER Population-Based Registries
Roman Mezencev, Yury O. Chernoff
Cancers (2020) Vol. 12, Iss. 4, pp. 796-796
Open Access | Times Cited: 23
Roman Mezencev, Yury O. Chernoff
Cancers (2020) Vol. 12, Iss. 4, pp. 796-796
Open Access | Times Cited: 23
Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea
Jihun Kang, Dong Wook Shin, Kyungdo Han, et al.
Current Problems in Cancer (2020) Vol. 44, Iss. 6, pp. 100578-100578
Closed Access | Times Cited: 23
Jihun Kang, Dong Wook Shin, Kyungdo Han, et al.
Current Problems in Cancer (2020) Vol. 44, Iss. 6, pp. 100578-100578
Closed Access | Times Cited: 23
Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies
Dandan Zhang, Ya‐Nan Ou, Yan Fu, et al.
Journal of Alzheimer s Disease (2022) Vol. 89, Iss. 1, pp. 367-380
Closed Access | Times Cited: 13
Dandan Zhang, Ya‐Nan Ou, Yan Fu, et al.
Journal of Alzheimer s Disease (2022) Vol. 89, Iss. 1, pp. 367-380
Closed Access | Times Cited: 13
The risk of dementia with the use of 5 alpha reductase inhibitors
Blayne Welk, Eric McArthur, Michael Ordon, et al.
Journal of the Neurological Sciences (2017) Vol. 379, pp. 109-111
Closed Access | Times Cited: 23
Blayne Welk, Eric McArthur, Michael Ordon, et al.
Journal of the Neurological Sciences (2017) Vol. 379, pp. 109-111
Closed Access | Times Cited: 23
The effects of androgen deprivation on working memory and quality of life in prostate cancer patients: The roles of hypothalamic connectivity
Shefali Chaudhary, Simon Zhornitsky, Alicia Roy, et al.
Cancer Medicine (2022) Vol. 11, Iss. 18, pp. 3425-3436
Open Access | Times Cited: 12
Shefali Chaudhary, Simon Zhornitsky, Alicia Roy, et al.
Cancer Medicine (2022) Vol. 11, Iss. 18, pp. 3425-3436
Open Access | Times Cited: 12
Neurocognitive deficits in older patients with cancer
Beatrice J. Edwards, Xiaotao Zhang, Ming Sun, et al.
Journal of Geriatric Oncology (2018) Vol. 9, Iss. 5, pp. 482-487
Closed Access | Times Cited: 20
Beatrice J. Edwards, Xiaotao Zhang, Ming Sun, et al.
Journal of Geriatric Oncology (2018) Vol. 9, Iss. 5, pp. 482-487
Closed Access | Times Cited: 20
